Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Vaccine for Protection Against Shigella sonnei Disease

Posted Sep 30 2008 5:00pm

Description of Invention:
Shigellosis is a global human health problem. Transmission usually occurs by contaminated food and water or through person-to-person contact. The bacterium is highly infectious by the oral route, and ingestion of as few as 10 organisms can cause an infection in volunteers. An estimated 200 million people worldwide suffer from shigellosis, with more than 650,000 associated deaths annually. A recent CDC estimate indicates the occurrence of over 440,000 annual shigellosis cases in the United States alone, approximately eighty percent (80%) of which are caused by Shigella sonnei. Shigella sonnei is more active in developed countries. Shigella infections are typically treated with a course of antibiotics. However, due to the emergence of multidrug resistant Shigella strains, a safe and effective vaccine is highly desirable. No vaccines against Shigella infection currently exist. Immunity to Shigellae is mediated largely by immune responses directed against the serotype specific O-polysaccharide. Claimed in the invention are compositions and methods for inducing an immunoprotective response against S. sonnei. Specifically, an attenuated bacteria capable of expressing an S. sonnei antigen comprised of the S. sonnei form I O-polysaccharide expressed from the S. sonnei rfb/rfc gene cluster is claimed. The inventors have shown that the claimed vaccine compositions showed one hundred percent (100%) protection against parenteral challenge with virulent S. sonnei in mice.

Inventors:
Dennis J Kopecko (FDA)
De Qi Xu (NIDCR)
John O Cisar (NIDCR)


Patent Status:
HHS, Reference No. E-210-2001/0
US, , Patent No. 7,541,043, Issued 02 Jun 2009
US, Application No. 12/474,223 filed 29 May 2009



Portfolios:
Infectious Diseases
Infectious Diseases - Vaccines
Rare Diseases



For Additional Information Please Contact:
Peter Soukas J.D.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325 Room 14,
Rockville, MD 20852-3804
United States
Email: soukasp@mail.nih.gov
Phone: 301-435-4646
Fax: 301-402-0220


Ref No: 589

Updated: 10/2008

Post a comment
Write a comment:

Related Searches